Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-16-103735
Filing Date
2016-05-19
Accepted
2016-05-19 19:32:08
Documents
1
Period of Report
2016-05-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v440540_4.html 4  
1 OWNERSHIP DOCUMENT v440540_4.xml 4 3869
  Complete submission text file 0001144204-16-103735.txt   5285
Mailing Address 2345 EASTLAKE AVENUE EAST SUITE 201 SEATTLE WA 98102
Business Address 2345 EASTLAKE AVENUE EAST SUITE 201 SEATTLE WA 98102 206.588.0256
ATOSSA GENETICS INC (Issuer) CIK: 0001488039 (see all company filings)

EIN.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O ATOSSA GENETICS INC. 1616 EASTLAKE AVE. E SUITE 510 SEATTLE WA 98102
Business Address
Guse Kyle (Reporting) CIK: 0001566618 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35610 | Film No.: 161664470